Clinical Trial Update: A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD) [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 safety study evaluating AT-100 (rhSP-D) in preterm neonates at high risk for bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• AT-100 (rhSP-D) (rhSP-D)

Snippet

Sponsor: Airway Therapeutics, Inc. | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED